Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial - European Urology
Selection of ongoing trials of pembrolizumab or atezolizumab in TNBC... | Download Scientific Diagram
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial | Nature Medicine
Ongoing trials of atezolizumab in NSCLC | Download Table
Atezolizumab plus Bevacizumab combination therapy compared to Sorafenib and Atezolizumab monotherapies for treatment of unresectable or metastatic hepatocellular carcinoma - Asian Pacific Digestive Week 2021 | Kuala Lumpur
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer - ScienceDirect
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials - European Journal of Cancer
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study) | Journal for ImmunoTherapy of Cancer
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC | NEJM
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial - The Lancet
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China | Journal of Hematology & Oncology | Full Text
A clinical trial to compare atezolizumab with a placebo in people with head and neck cancer who are at a high risk of their cancer returning or getting worse after completion of
Study schematics of ongoing Phase iii trials of atezolizumab in... | Download Scientific Diagram
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non–Small Cell Lung Cancer: Results From a Phase 1b Trial - ScienceDirect
Atezolizumab - Wikipedia
Imugene Entered into a Clinical Trial Supply Agreement with Roche to Evaluate PD1-Vaxx + Atezolizumab for the Treatment of Lung Cancer
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer - Annals of Oncology
FLASCO / Atezolizumab Clinical Trials
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial - The Lancet
Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials - Journal of Thoracic Oncology
Atezolizumab for Urinary Bladder Cancer Clinical Trial | Power
